We could get some news on the LOI with Macular very soon.
From the[url] 10K
In August 2012, we entered into a letter of intent with Macular Health, LLC (“ Macular ”), a leading manufacturer and distributor of macular degeneration nutritional supplements to license our proprietary delivery technology for the development of DROP formulations of Macular’s products. As of the date of this report, we have advanced through four stages of product development and currently are preparing final formulations for clinical testing, which we anticipate will be facilitated by Macular in early 2013. [/url][tag]insert-text-here[/tag]
Market Data 
Markets 
AI
